---
title: Developments in epigenetic reprogramming and potential therapies
videoId: aku3ufVb-AQ
---

From: [[jessemichels]] <br/> 

Epigenetic reprogramming is an exciting area of research that aims to achieve dramatic age reduction by modifying a small number of genes, typically four or five, or even just three <a class="yt-timestamp" data-t="12:52">[12:52]</a>. This concept has led to the emergence of a new industry with several startup companies exploring its potential <a class="yt-timestamp" data-t="13:06">[13:06]</a>.

## How Epigenetic Reprogramming Works

At its core, [[dna_methylation_and_its_influence_on_cell_differentiation | epigenetics]] refers to chemical modifications of DNA that modulate genes, instructing them whether to be turned on or off <a class="yt-timestamp" data-t="06:50">[06:50]</a>. These modifications, such as DNA methylation, are crucial for cell differentiation, allowing stem cells to develop into various cell types and tissues <a class="yt-timestamp" data-t="07:32">[07:32]</a>.

Epigenetic reprogramming involves administering certain viruses into target organs, which then stimulate the regrowth or rejuvenation of tissues <a class="yt-timestamp" data-t="13:33">[13:33]</a>. The idea is that by altering these epigenetic marks, the biological age of cells can be reversed <a class="yt-timestamp" data-t="06:19">[06:19]</a>.

## Current Applications and Potential

One notable application of epigenetic reprogramming is in the rejuvenation and regrowth of the optic nerve <a class="yt-timestamp" data-t="13:23">[13:23]</a>. For instance, a protocol developed by David Sinclair from Harvard aims to treat a damaged optic nerve, such as one affected by glaucoma, by administering specific viruses into the eye <a class="yt-timestamp" data-t="13:16">[13:16]</a>, <a class="yt-timestamp" data-t="13:28">[13:28]</a>, <a class="yt-timestamp" data-t="13:35">[13:35]</a>.

The potential applications of this technology are vast, with the speaker suggesting that the idea could be applied to "any other organs" and that "the sky is the limit" <a class="yt-timestamp" data-t="13:41">[13:41]</a>, <a class="yt-timestamp" data-t="13:46">[13:46]</a>.

## Industry and Investment in Epigenetic Therapies

The promise of epigenetic reprogramming has already attracted significant investment, leading to the formation of several [[biotech_industry_advances_and_investments | biotech startup companies]] <a class="yt-timestamp" data-t="13:06">[13:06]</a>. This reflects the growing interest in [[advancements_in_longevity_research_and_antiaging_interventions | longevity research]] and the pursuit of methods to slow or defeat aging <a class="yt-timestamp" data-t="02:25">[02:25]</a>, <a class="yt-timestamp" data-t="02:28">[02:28]</a>.

## Epigenetic Clocks and Measuring Age Reversal

The development of [[epigenetic_clocks_and_their_role_in_aging_and_predicting_death | epigenetic clocks]], such as the pan-tissue clock created by Dr. Steve Horvath in 2013, allows researchers to estimate a person's age with a narrow standard deviation based on their [[dna_methylation_and_its_influence_on_cell_differentiation | DNA methylation profile]] <a class="yt-timestamp" data-t="00:30">[00:30]</a>, <a class="yt-timestamp" data-t="01:33">[01:33]</a>. These clocks are algorithms that process blood samples to determine biological age <a class="yt-timestamp" data-t="01:43">[01:43]</a>.

The ability to accurately measure biological age is crucial for evaluating the effectiveness of anti-aging treatments and interventions <a class="yt-timestamp" data-t="04:56">[04:56]</a>. If an anti-aging treatment successfully reverses epigenetic age, it can be detected relatively quickly, rather than waiting decades for traditional longevity trials to conclude <a class="yt-timestamp" data-t="06:06">[06:06]</a>, <a class="yt-timestamp" data-t="06:11">[06:11]</a>, <a class="yt-timestamp" data-t="06:19">[06:19]</a>. This makes epigenetic clocks valuable "surrogate end points" for clinical trials <a class="yt-timestamp" data-t="05:51">[05:51]</a>.

## Histone Modifications vs. DNA Methylation

While DNA methylation is widely studied due to readily available and relatively cheap technology <a class="yt-timestamp" data-t="14:20">[14:20]</a>, <a class="yt-timestamp" data-t="14:23">[14:23]</a>, many experts believe that histone modifications are superior <a class="yt-timestamp" data-t="13:56">[13:56]</a>. This is because histone modifications are more dynamic, allowing for quicker responses to factors like a healthy diet <a class="yt-timestamp" data-t="14:08">[14:08]</a>. In contrast, methylation is often more stable, which can be a drawback when seeking dynamic changes <a class="yt-timestamp" data-t="14:02">[14:02]</a>.

Despite the higher costs associated with studying histone modifications, developing epigenetic clocks based on them is considered a "missed opportunity" that should be pursued <a class="yt-timestamp" data-t="14:27">[14:27]</a>, <a class="yt-timestamp" data-t="14:32">[14:32]</a>, <a class="yt-timestamp" data-t="14:34">[14:34]</a>.

## Challenges and Future Outlook

A major challenge in longevity research is the high cost and lengthy duration of traditional clinical trials <a class="yt-timestamp" data-t="04:44">[04:44]</a>, <a class="yt-timestamp" data-t="05:19">[05:19]</a>. Epigenetic clocks offer a solution by providing a proxy for death, allowing for quicker assessment of interventions <a class="yt-timestamp" data-t="04:48">[04:48]</a>, <a class="yt-timestamp" data-t="05:48">[05:48]</a>. Reducing regulatory burdens and lowering costs are vital for opening up the field to more innovative and "crazy ideas" <a class="yt-timestamp" data-t="10:11">[10:11]</a>, <a class="yt-timestamp" data-t="10:16">[10:16]</a>.

There is also hope that by routinely collecting blood samples in various clinical trials and running epigenetic clocks, unexpected beneficial side effects of treatments on longevity might be discovered <a class="yt-timestamp" data-t="10:56">[10:56]</a>, <a class="yt-timestamp" data-t="11:17">[11:17]</a>.